Addex Therapeutics (ADXN) EBT Margin (2019 - 2025)
Addex Therapeutics' EBT Margin came in at -739347.58% for Q4 2025, down 660446.32 percentage points from -78901.26% a year earlier and down 734041.33 percentage points from the prior quarter.
Powered by 
Analysis
Addex Therapeutics (ADXN) EBT Margin (2019 - 2025) Analysis & Trends
For FY2025, Addex Therapeutics' EBT Margin was -22829.93%, down 21615.06 percentage points from FY2024.
- EBT Margin carries a five-year change of -22474.02 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -1214.88% in FY2024 (-1059.87 pp), -155.00% in FY2023 (+604.53 pp), -759.54% in FY2022 (-233.12 pp) and -526.42% in FY2021 (-170.50 pp).
- The Q4 2025 figure represents the lowest quarterly EBT Margin in data going back to Q1 2019.
- Year-over-year, EBT Margin increased in 1 of the last six quarters, with an average year-over-year change of -124159.88 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q3 2021 (a gain of 11624.09 percentage points), and the weakest in Q4 2025 (a drop of 660446.32 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Addex Therapeutics | 2.64 Mn | 2.64 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -739,347.58% |
| Sep 30, 2025 | -5,306.25% |
| Dec 31, 2024 | -78,901.26% |
| Sep 30, 2024 | -2,837.40% |
| Jun 30, 2024 | -1,263.70% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | -585.21% |
| Sep 30, 2023 | -216.86% |
| Jun 30, 2023 | -82.65% |
| Mar 31, 2023 | -73.87% |
| Dec 31, 2022 | -3,511.67% |
| Sep 30, 2022 | -1,003.29% |
| Jun 30, 2022 | -3,938.42% |
| Mar 31, 2022 | -2,454.82% |
| Dec 31, 2021 | -3,862.23% |
| Sep 30, 2021 | -527.59% |
| Jun 30, 2021 | -472.51% |
| Mar 31, 2021 | -312.67% |
| Dec 31, 2020 | -706.24% |
| Sep 30, 2020 | -12,151.68% |
API Access
Addex Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();